Furthermore, we evaluated OTUD6B expression at different tumor stages according to the World Health Organization (WHO) and found that it was highly expressed in most advanced tumors including LUAD, ESAD, STAD, BLCA, BRCA, COADREAD, LIHC, and OSCC (Figures 3A–L). Here, OTUD6B is linked to neoplasm.